XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating Activities:    
Net loss $ (1,302,564) $ (1,042,492)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation and amortization 337,200 93,859
Warranty provision 12,361
Inventory obsolescence 91,976 (186,772)
Share-based compensation 433,063 943,923
Deferred income taxes 2,793,590 (754,569)
Changes in operating assets and liabilities:    
Accounts receivable, net (496,642) 1,024,797
Inventories, net (239,360) (760,351)
Prepaid expenses and other 153,576 (22,923)
Other assets (60,615) 180,063
Accounts payable 376,864 1,223,342
Accrued liabilities 54,610 291,725
Net cash provided by operating activities 2,154,059 990,602
Investing Activities:    
Purchases of marketable securities (3,208,197) (2,304,263)
Proceeds from maturities of marketable securities 3,335,639 2,402,861
Capital expenditures (166,845) (171,735)
Purchase of Genasys, net of cash and restricted cash acquired (2,246,545)
Patent costs paid (7,789)
Net cash used in investing activities (2,285,948) (80,926)
Financing Activities:    
Proceeds from exercise of stock options 1,027,719
Repurchase of common stock (500,272)
Proceeds from the issuance of promissory notes 63,144
Payments on promissory notes (786,437)
Net cash used in financing activities (195,846)
Effect of foreign exchange rate on cash (1,594)
Net (decrease) increase in cash, cash equivalents, and restricted cash (329,329) 909,676
Cash, cash equivalents and restricted cash, beginning of period 12,803,887 13,466,711
Cash, cash equivalents and restricted cash, end of period 12,474,558 14,376,387
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 12,803,887 13,466,711
Interest paid 12,235
Noncash investing and financing activities:    
Change in unrealized loss on marketable securities (11,064) (1,978)
Business combinations accounted for as a purchase:    
Fair value of assets acquired 5,520,504
Cash paid (3,011,439)
Liabilities assumed $ 2,509,065